Cochrane · systematic review · CD011025
Transcranial magnetic stimulation for the treatment of epilepsy
Walton, D, Spencer, DC, Nevitt, SJ, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 33.3%Low 2 · 66.7%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Show all 2 versionsRepetitive transcranial magnetic stimulation (rTMS) compared with control for epilepsy
Population: adults and children with epilepsy
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Reduction in seizure frequency: the proportion of people with a 50% or greater reduction in seizure frequency following the treatment period Repetitive transcranial magnetic stimulation (rTMS) vs control | no estimate extracted | 4 studies · 109 participants | Low Downgraded: risk of bias, imprecision |
Reduction in seizure frequency: the difference in pre‐ and post‐treatment seizure rates Repetitive transcranial magnetic stimulation (rTMS) vs control | no estimate extracted | 8 studies · 225 participants | Low Downgraded: risk of bias |
Improvement in quality of life: the difference in quality of life scores for participants surveyed before and after treatment Repetitive transcranial magnetic stimulation (rTMS) vs control | no estimate extracted | 1 study · 7 participants | Very low Downgraded: imprecision |